ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia

類似資料

• ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
  著者:: Clemence Virely, 等
  出版事項: (2020-10-01)
• MCL1 inhibition to enhance the efficacy of MYB targeting in pediatric acute myeloid leukemia
  著者:: Alexia Tsakaneli, 等
  出版事項: (2026-05-01)
• Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
  著者:: Sandra Cantilena, 等
  出版事項: (2022-06-01)
• High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments
  著者:: Jack Bartram, 等
  出版事項: (2018-03-01)
• Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
  著者:: Hayden L. Bell, 等
  出版事項: (2023-09-01)